The FDA-Approved Anti-Asthma Medicine Ciclesonide Inhibits Lung Cancer Stem Cells through Hedgehog Signaling-Mediated SOX2 Regulation

Ciclesonide is an FDA-approved glucocorticoid (GC) used to treat asthma and allergic rhinitis. However, its effects on cancer and cancer stem cells (CSCs) are unknown. Our study focuses on investigating the inhibitory effect of ciclesonide on lung cancer and CSCs and its underlying mechanism. In thi...

Descripción completa

Detalles Bibliográficos
Autores principales: Choi, Hack Sun, Kim, Su-Lim, Kim, Ji-Hyang, Lee, Dong-Sun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7038186/
https://www.ncbi.nlm.nih.gov/pubmed/32033067
http://dx.doi.org/10.3390/ijms21031014

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7038186/
https://www.ncbi.nlm.nih.gov/pubmed/32033067
http://dx.doi.org/10.3390/ijms21031014

Ejemplares similares